TABLE 3.

Odds ratio of clinical outcomes comparing obese and non-obese patients.

Clinical outcomes	Crude			Adjusted*
	OR	95% CI	P-value	OR	95% CI	P-value
Stroke or SE	0.43	0.21–0.88	<0.001	0.40	0.18–0.89	0.024
Bleeding	0.42	0.26–0.66	<0.001	0.44	0.26–0.74	0.002
AF admission	0.99	0.73–1.38	0.994	0.93	0.67–1.30	0.678
HF admission	0.53	0.37–0.75	<0.001	0.61	0.41–0.90	0.013
All-cause death	0.69	0.49–0.97	0.035	0.69	0.47–1.03	0.066
Composite outcome	0.69	0.54–0.83	<0.001	0.65	0.50–0.84	0.001

AF, atrial fibrillation; CI, confidence interval; HF, heart failure; OR, odds ratio; SE, systemic embolism. *Adjusted for sex, type of AF, hypertension, diabetes, coronary artery disease, HF, history of previous stroke or major bleeding, peripheral vascular disease, abnormal renal function, alcohol and smoking history, and baseline medications (aspirin, clopidogrel, angiotensin-converting enzyme inhibitors, ARB, digoxin, statins, and warfarin).